Dolby Laboratories (DLB) executive files to sell 7,667 shares after option exercise

Rhea-AI Filing Summary

Dolby Laboratories, Inc. (DLB) insider John Couling filed to sell common stock under a planned transaction. The filing lists 7,667 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $460,003.90, in connection with a stock option exercise

Key Figures

Planned shares to be sold: 7,667 shares Aggregate market value of planned sale: $460,003.90 Shares sold on July 1, 2026: 7,667 shares +4 more

7 metrics

Planned shares to be sold 7,667 shares Common stock to be sold in connection with stock option exercise dated August 3, 2026

Aggregate market value of planned sale $460,003.90 Estimated market value for 7,667 common shares to be sold

Shares sold on July 1, 2026 7,667 shares Common stock sold for $407,894.37

Proceeds on July 1, 2026 sale $407,894.37 Sale of 7,667 common shares

Shares sold on June 1, 2026 7,666 shares Common stock sold for $426,419.72

Shares sold on May 5, 2026 7,666 shares Common stock sold for $441,209.73

Shares sold on May 4, 2026 4,688 shares Common stock sold for $274,083.92

Key Terms

Form 144, Stock Option Exercise, Executive Financial Services

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 08/03/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:12 PM Accepted by SEC EDGAR 08/03/2026 - 04:11 PM Learn about SEC filing dates

FAQ

What does Dolby Laboratories (DLB) insider John Couling plan to sell under this Form 144?

John Couling plans to sell 7,667 common shares of Dolby Laboratories, Inc. The filing reports an aggregate market value of $460,003.90 for these shares in connection with a stock option exercise dated August 3, 2026.

What is the nature of the planned Dolby (DLB) share transaction on August 3, 2026?

The planned transaction is a stock option exercise with subsequent sale of 7,667 common shares. The shares are to be sold for an aggregate market value of $460,003.90 through Morgan Stanley Smith Barney LLC Executive Financial Services.

Which broker is handling the planned Dolby (DLB) share sale for John Couling?

The planned sale of 7,667 Dolby common shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as disclosed in the Form 144 information.

What Dolby (DLB) stock sales has John Couling made in the past three months?

The filing lists sales of 7,667 shares for $407,894.37 on July 1, 2026, 7,666 shares for $426,419.72 on June 1, 2026, 7,666 shares for $441,209.73 on May 5, 2026, and 4,688 shares for $274,083.92 on May 4, 2026.

On which exchange are the Dolby (DLB) shares in this Form 144 listed?

The common shares referenced in this Form 144 are listed on the NYSE. The filing associates the planned sale of 7,667 shares with the NYSE listing of Dolby Laboratories, Inc. common stock.

Does the Form 144 for Dolby (DLB) specify how consideration will be paid for the shares?

Yes. The Form 144 states that consideration for the 7,667 common shares tied to the stock option exercise dated August 3, 2026, will be paid in cash, as indicated in the securities information section.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7667	460003.90	59416894	08/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/03/2026	Stock Option Exercise	Issuer			7667	08/03/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHN COULING 1275 Market Street San Francisco CA 94103-1410	Common	07/01/2026	7667	407894.37
JOHN COULING 1275 Market Street San Francisco CA 94103-1410	Common	06/01/2026	7666	426419.72
JOHN COULING 1275 Market Street San Francisco CA 94103-1410	Common	05/05/2026	7666	441209.73
JOHN COULING 1275 Market Street San Francisco CA 94103-1410	Common	05/04/2026	4688	274083.92

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)